626 related articles for article (PubMed ID: 24021703)
21. Biomarkers in critically ill patients with systemic inflammatory response syndrome or sepsis supplemented with high-dose selenium.
Brodska H; Valenta J; Malickova K; Kohout P; Kazda A; Drabek T
J Trace Elem Med Biol; 2015; 31():25-32. PubMed ID: 26004888
[TBL] [Abstract][Full Text] [Related]
22. Effects of high doses of selenium, as sodium selenite, in septic shock patients a placebo-controlled, randomized, double-blind, multi-center phase II study--selenium and sepsis.
Forceville X
J Trace Elem Med Biol; 2007; 21 Suppl 1():62-5. PubMed ID: 18039501
[TBL] [Abstract][Full Text] [Related]
23. High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation.
Manzanares W; Biestro A; Torre MH; Galusso F; Facchin G; Hardy G
Intensive Care Med; 2011 Jul; 37(7):1120-7. PubMed ID: 21445641
[TBL] [Abstract][Full Text] [Related]
24. High-dose intravenous selenium does not improve clinical outcomes in the critically ill: a systematic review and meta-analysis.
Manzanares W; Lemieux M; Elke G; Langlois PL; Bloos F; Heyland DK
Crit Care; 2016 Oct; 20(1):356. PubMed ID: 27788688
[TBL] [Abstract][Full Text] [Related]
25. Parenteral selenium supplementation in critically ill patients--effects on antioxidant metabolism.
Lehmann C; Weber M; Krausch D; Wauer H; Newie T; Rohr U; Hensel M; Glatzel E; Priem F; Grune T; Kox WJ
Z Ernahrungswiss; 1998; 37 Suppl 1():106-9. PubMed ID: 9558739
[TBL] [Abstract][Full Text] [Related]
26. Selenoprotein P, rather than glutathione peroxidase, as a potential marker of septic shock and related syndromes.
Forceville X; Mostert V; Pierantoni A; Vitoux D; Le Toumelin P; Plouvier E; Dehoux M; Thuillier F; Combes A
Eur Surg Res; 2009; 43(4):338-47. PubMed ID: 19779296
[TBL] [Abstract][Full Text] [Related]
27. Update on clinical micronutrient supplementation studies in the critically ill.
Berger MM; Shenkin A
Curr Opin Clin Nutr Metab Care; 2006 Nov; 9(6):711-6. PubMed ID: 17053424
[TBL] [Abstract][Full Text] [Related]
28. [Effect of selenium administration on various laboratory parameters of patients at risk for sepsis syndrome].
Lehmann C; Egerer K; Weber M; Krausch D; Wauer H; Newie T; Kox WJ
Med Klin (Munich); 1997 Sep; 92 Suppl 3():14-6. PubMed ID: 9417487
[TBL] [Abstract][Full Text] [Related]
29. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome.
Angstwurm MW; Schottdorf J; Schopohl J; Gaertner R
Crit Care Med; 1999 Sep; 27(9):1807-13. PubMed ID: 10507602
[TBL] [Abstract][Full Text] [Related]
30. Effect of high-dose sodium selenite in cardiac surgery patients: A randomized controlled bi-center trial.
Schmidt T; Pargger H; Seeberger E; Eckhart F; von Felten S; Haberthür C
Clin Nutr; 2018 Aug; 37(4):1172-1180. PubMed ID: 28502744
[TBL] [Abstract][Full Text] [Related]
31. Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis.
Huang TS; Shyu YC; Chen HY; Lin LM; Lo CY; Yuan SS; Chen PJ
PLoS One; 2013; 8(1):e54431. PubMed ID: 23372722
[TBL] [Abstract][Full Text] [Related]
32. Selenium supplementation in critically ill patients: a systematic review and meta-analysis.
Landucci F; Mancinelli P; De Gaudio AR; Virgili G
J Crit Care; 2014 Feb; 29(1):150-6. PubMed ID: 24135013
[TBL] [Abstract][Full Text] [Related]
33. Antioxidant therapy in critical care--is the microcirculation the primary target?
Biesalski HK; McGregor GP
Crit Care Med; 2007 Sep; 35(9 Suppl):S577-83. PubMed ID: 17713412
[TBL] [Abstract][Full Text] [Related]
34. Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients.
Angstwurm MW; Schopohl J; Gaertner R
Eur J Endocrinol; 2004 Jul; 151(1):47-54. PubMed ID: 15248821
[TBL] [Abstract][Full Text] [Related]
35. [Selenium substitution after cardiac arrest].
Busch HJ
Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 11():S419-21. PubMed ID: 19998235
[No Abstract] [Full Text] [Related]
36. Practicalities of selenium supplementation in critically ill patients.
Angstwurm MW; Gaertner R
Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):233-8. PubMed ID: 16607122
[TBL] [Abstract][Full Text] [Related]
37. Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose-finding study.
Heyland DK; Dhaliwalm R; Day A; Drover J; Cote H; Wischmeyer P
JPEN J Parenter Enteral Nutr; 2007; 31(2):109-18. PubMed ID: 17308251
[TBL] [Abstract][Full Text] [Related]
38. Oxidative stress and role of antioxidant supplementation in critical illness.
Mishra V
Clin Lab; 2007; 53(3-4):199-209. PubMed ID: 17447658
[TBL] [Abstract][Full Text] [Related]
39. [Update glutamine and antioxidants in critically ill patients].
Elke G; Felbinger TW; Mayer K
Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Feb; 49(2):124-32; quiz 133. PubMed ID: 24563403
[TBL] [Abstract][Full Text] [Related]
40. Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation.
Elango N; Samuel S; Chinnakkannu P
Clin Chim Acta; 2006 Nov; 373(1-2):92-8. PubMed ID: 16831410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
